Published in Obesity and Diabetes Week, December 1st, 2003
Total market sales for all forms of Metformin were $1.6 billion with sales of $452.4 million for the Metformin Extended-release formulation (IMS - MAT: June 2003).
Metformin Hydrochloride Extended-release Tablets (Glucophage XR) as monotherapy is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week